Medical Marijuana, Inc. CEO to Speak on Medical Cannabis Research at 4th Annual Cannabis World Congress and Business Expo in New York

Company Subsidiary HempMeds® to Exhibit at Expo and Also Showcase the Newly Launched Dixie Botanicals Product “Dixie Kicks”

SAN DIEGO, June 13, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that at the 4th Annual Cannabis World Congress and Business Expo (CWCBE), taking place in New York City from June 14-16, the Company’s Chief Executive Officer Dr. Stuart Titus will speak on medical cannabis research on June 15. Medical Marijuana, Inc. subsidiary HempMeds® will also be showing retail-ready cannabis products and exhibiting its line of CBD hemp oil products at the Expo in booth #100.

“I am looking forward to the opportunity to speak to the audience at CWCBE about the healing properties of cannabis and recent breakthroughs in medical cannabis research,” said CEO of Medical Marijuana, Inc. Dr. Stuart Titus. “With the first-ever import permits for Real Scientific Hemp Oil™ (RSHO™) from the governments of Mexico, Brazil and Paraguay, there is clearly an expanding global market for hemp cannabidiol (CBD) products. With new research and clinical trials also developing, we have really only scratched the surface in uncovering the plethora of medical benefits of CBD.”

Visitors who stop by the HempMeds® booth can expect to learn more about the Company’s unique line of CBD hemp oil products, including its award-winning brands like Dixie Botanicals® and RSHO™. The Company will also be revealing a new Dixie Botanicals® hemp-based energy product “Dixie Kicks” for the first time at the Expo.

Dr. Titus will be speaking on June 15 at 11:00 a.m. in room #1A08.

For more information about the CWCBE, visit

About HempMeds®
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.  The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act.  The Company does sell and distribute hemp-based products.

Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P: 888-829- 0070
[email protected]